L
Lightcast Discovery
Lightcast is developing a new platform for manipulating cells and reagents, enabling game-changing workflows for pharma
About Lightcast Discovery
Lightcast Discovery Ltd., a life science tools company, has recently secured $49 million in Series B financing to commercialize its innovative single-cell functional analysis platform. This platform is a novel tool in the field of life sciences, providing detailed analysis at the cellular level. The company operates in the biotechnology market, serving clients such as research institutions, pharmaceutical companies, and other life science organizations that require high-precision cellular analysis.
Read full description
The company's business model revolves around the development and commercialization of its single-cell platform. The platform provides a unique service in the market, allowing for in-depth functional analysis of individual cells. This can be invaluable in various fields, including drug discovery, disease research, and personalized medicine. The company generates revenue by selling access to its platform and providing related services.
The recent funding round, led by M Ventures, will enable Lightcast to further develop its platform and expand its market reach. The round also saw participation from existing investors such as ARCH Venture Partners, Illumina Ventures, OMX Ventures, +ND Capital, and Longwall Ventures. In addition to the funding news, Lightcast announced the appointment of Paul Steinberg as its Chief Commercial Officer (CCO), signaling the company's intent to strengthen its commercial capabilities.
In summary, Lightcast Discovery is a promising startup in the life sciences sector, with a unique product offering and a strong financial backing. The company is well-positioned to make a significant impact in the field of single-cell analysis.
At a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Cambridge, United Kingdom
- Employees
- 98
- Open positions
- 1
- Dealroom signal
- 64.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, uk is8 digital and technologies, uk is8 life sciences, UKSU, UKSU2010, AI Drug Discovery, BIA Techbio UK, Techbio, Hard Tech
- Business model
- Manufacturing
Latest news
Press, funding announcements and product moves mentioning Lightcast Discovery.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Apr 2026 | $20M | $190M | Longwall Ventures · M Ventures · Illumina Ventures · +ND Capital | ↗ |
| LATE VCOther financing | Feb 2026 | $13M | $251M | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Lightcast Discovery is 2.3K monthly website visits, down 52.1% over the last three months. Lightcast Discovery's team declined 8.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
M Ventures
+ND Capital
OMX Ventures
ARCH Venture Partners
Longwall Ventures
Illumina Ventures
Other known investors1 additional known investor
University of Warwick
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lightcast Discovery on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lightcast Discovery’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.